Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference50 articles.
1. Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H et al. (1992). Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. Blood 80: 2604–2609.
2. Arner ES, Holmgren A . (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102–6109.
3. Bhalla KN . (2005). Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 23: 3971–3993.
4. Breslow R, Jursic B, Yan ZF, Friedman E, Leng L, Ngo L et al. (1991). Potent cytodifferentiating agents related to hexamethylene bisacetamide. Proc Natl Acad Sci USA 88: 5542–5546.
5. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C et al. (2000). Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60: 5165–5170.
Cited by
559 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献